Clinical Trial Update: Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fecal biotherapy to induce remission in active ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED